5 results
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
or pending) or request from a Regulatory Authority seeking the recall, withdrawal, suspension or seizure of any Company Product; or
any written notice
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
) or request from a Regulatory Authority seeking the recall, withdrawal, suspension or seizure of any Company Product or (iv) any written notice or other
6-K
BLU
Bellus Health Inc
15 Nov 06
Current report (foreign)
12:00am
trial and the ongoing open-label
extension study. You may recall that, among the various elements raised in the
approvable letter, the FDA had stated
6-K
BLU
Bellus Health Inc
16 Nov 05
Current report (foreign)
12:00am
progress, beginning with
Fibrillex(TM), our investigational product candidate for the treatment of
Amyloid A (AA) Amyloidosis.
As you will recall, we
6-K
BLU
Bellus Health Inc
16 Aug 05
Current report (foreign)
12:00am
).
As you will recall, we released during the second quarter the results from the
Phase II/III clinical trial, data which we then submitted to the U.S. Food
- Prev
- 1
- Next